NCT01695187

NB-001 Treatment of Recurrent Herpes Labialis

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study of NB-001 Treatment of Recurrent Herpes Labialis

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 362 (actual)
• Sponsor: NanoBio Corporation · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a study to test the hypothesis that time to healing of a cold sore will be lower in the active treatment arm of the study when compared to the vehicle (placebo). Subjects with a history of cold sores will be enrolled and administered active treatment or placebo in a blinded manner. Subjects will then be followed to assess time to healing.

Conditions

• Herpes Labialis

Interventions

Type	Name	Description
DRUG	NB-001 (0.3%)	Topical administration at least five times throughout the day
DRUG	Placebo

Timeline

• Start date: 2012-10-01
• Primary completion: 2013-06-01
• Completion: 2013-07-01
• First posted: 2012-09-27
• Last updated: 2013-06-14

Locations

12 sites across 1 country: United States